Dementia definitions
Executive Summary
Psychopharmacologic Drugs Advisory Committee will discuss drug development for Alzheimer's and other dementias March 9. The committee will specifically address the problem of how to identify, define and name clinical entities that fall under the dementia category in order to prevent misleading labeling. The meeting will begin at 8:00 a.m. at the Holiday Inn in Gaithersburg, Md